• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay.

作者信息

Taylor A K, Linkhart S, Mohan S, Christenson R A, Singer F R, Baylink D J

机构信息

Jerry Pettis Veterans Administration Hospital, Loma Linda, California 92357.

出版信息

J Clin Endocrinol Metab. 1990 Feb;70(2):467-72. doi: 10.1210/jcem-70-2-467.

DOI:10.1210/jcem-70-2-467
PMID:2298858
Abstract

Reliable markers of bone formation are essential to the investigation of metabolic bone disorders. In this regard, evidence indicates that circulating levels of human osteocalcin (OC) correlate with the skeletal isoenzyme of alkaline phosphatase and can be used as an index of bone formation. A disadvantage of using serum OC as a marker of formation is its diurnal variation. To address this problem we carried out our studies to determine the usefulness of urine in the assessment of bone turnover. Using a midmolecule specific human OC RIA, we were able to detect OC in urine of normal adults (42 mugeq/g creatinine), normal children (849 mu/geq/g creatinine), and Paget's disease patients (613 mugeq/g creatinine). Immunoreactive fragments of OC in human urine and human serum were separated by high pressure liquid chromatography. Multiple fragments were found in normal adult urine that were not detected in normal adult serum. Uremic and Paget's disease sera contain several immunoreactive forms of OC, other than the intact molecule, not found in normal adult serum. Additionally, both Paget's disease sera and urine contained a specific peak of immunoreactive material, eluting at 25% acetonitrile, that was not found in any other serum or urine tested. Urinary OC (uOC) correlated with both skeletal alkaline phosphatase (r = 0.91) and serum OC (r = 0.83), indices of skeletal formation. While uOC has a diurnal variation similar to that of serum OC, determinations of 24-h uOC give integrated values of daily bone turnover rates. Z-Score analysis indicates that uOC (z = 14.04) is better able to distinguish between normal children with high bone turnover and normal adults than either skeletal alkaline phosphatase (z = 8.87) or serum OC (z = 9.01).

摘要

相似文献

1
Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay.
J Clin Endocrinol Metab. 1990 Feb;70(2):467-72. doi: 10.1210/jcem-70-2-467.
2
A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients.在对骨质疏松症患者进行阿仑膦酸钠短期治疗期间,尿中分子骨钙素检测比血清中分子骨钙素检测具有更高的鉴别能力。
Bone. 2002 Jul;31(1):62-9. doi: 10.1016/s8756-3282(02)00793-7.
3
A heterogeneity in serum osteocalcin N-terminal fragments in Paget's disease: a comparison with other biochemical indices in pre- and postmenopause.佩吉特病患者血清骨钙素N端片段的异质性:绝经前后与其他生化指标的比较
Calcif Tissue Int. 1998 Dec;63(6):459-65. doi: 10.1007/s002239900558.
4
Characterization of aged osteocalcin fragments derived from bone resorption.源自骨吸收的老化骨钙素片段的表征
Clin Lab. 2004;50(9-10):585-98.
5
Demonstration of the predominant urine osteocalcin fragments detectable by two-site immunoassays.
J Bone Miner Res. 1999 Mar;14(3):431-8. doi: 10.1359/jbmr.1999.14.3.431.
6
Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro.体内和体外生成的人骨钙素免疫反应形式的表征
J Bone Miner Res. 1994 Feb;9(2):255-64. doi: 10.1002/jbmr.5650090215.
7
Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay.采用人特异性双位点免疫放射分析法定量测定血清骨钙素。
J Bone Miner Res. 1992 Dec;7(12):1389-98. doi: 10.1002/jbmr.5650071206.
8
Non-invasive evaluation of bone formation: measurements of serum alkaline phosphatase, whole body retention of diphosphonate and serum osteocalcin in metabolic bone disorders and thyroid disease.
Scand J Clin Lab Invest. 1988 Nov;48(7):611-9.
9
Urinary osteocalcin as a marker of bone metabolism.尿骨钙素作为骨代谢的标志物。
Clin Chem. 2005 Mar;51(3):618-28. doi: 10.1373/clinchem.2004.043901. Epub 2005 Jan 13.
10
Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.用一种新的胶原蛋白降解标志物评估代谢性骨病患者的骨吸收情况。
J Clin Endocrinol Metab. 1994 Sep;79(3):780-5. doi: 10.1210/jcem.79.3.8077361.

引用本文的文献

1
Anti-Menopausal Effect of Soybean Germ Extract and in the Ovariectomized Rat Model.大豆胚芽提取物和染料木黄酮对去卵巢大鼠模型的抗更年期作用。
Nutrients. 2023 Oct 23;15(20):4485. doi: 10.3390/nu15204485.
2
Comparison of Bone Turnover Biomarkers in Serum and Urine Measured on an Automated Analytical Platform.血清和尿液中骨转换生物标志物在自动化分析平台上的比较。
J Appl Lab Med. 2021 Apr 29;6(3):750-755. doi: 10.1093/jalm/jfaa172.
3
Association of serum osteocalcin levels with glucose metabolism in trauma patients.创伤患者血清骨钙素水平与糖代谢的关系
Medicine (Baltimore). 2020 Sep 4;99(36):e21901. doi: 10.1097/MD.0000000000021901.
4
The role of osteocalcin in human glucose metabolism: marker or mediator?骨钙素在人类葡萄糖代谢中的作用:标志物还是介导物?
Nat Rev Endocrinol. 2013 Jan;9(1):43-55. doi: 10.1038/nrendo.2012.201. Epub 2012 Nov 13.
5
Vitamin K-dependent carboxylation of osteocalcin: friend or foe?维生素 K 依赖性骨钙素羧化:是敌是友?
Adv Nutr. 2012 Mar 1;3(2):149-57. doi: 10.3945/an.112.001834.
6
Bone turnover markers: understanding their value in clinical trials and clinical practice.骨转换标志物:了解其在临床试验和临床实践中的价值。
Osteoporos Int. 2009 Jun;20(6):843-51. doi: 10.1007/s00198-009-0838-9. Epub 2009 Feb 4.
7
Biochemical markers of bone turnover: part I: biochemistry and variability.骨转换的生化标志物:第一部分:生物化学与变异性
Clin Biochem Rev. 2005 Nov;26(4):97-122.
8
New developments in biochemical markers for osteoporosis.骨质疏松症生化标志物的新进展。
Calcif Tissue Int. 1996;59 Suppl 1:S2-9. doi: 10.1007/s002239900168.
9
Serum osteocalcin in metabolic bone diseases: what is its real significance?
J Endocrinol Invest. 1993 Apr;16(4):277-9. doi: 10.1007/BF03348831.